FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

The FDA has approved the first first anti-inflammatory drug for cardiovascular disease called LODOCO (colchicine) The recently approved medication has been shown to reduce cardiac event risk in adults with atherosclerotic cardiovascular disease (ASCVD) or with multiple risk factors by an additional 31% compared to an additional 31% treatment.

The most common side effect with this medication is gastrointestinal upset.

The FDA recently approved the firs The Food and Drug Administration di FDA scular disease call first DOCO (colchicine) The medication has been shown to reduce cardiac event risk in adul 0.5 with atherosclerotic cardiovascular disease (ASCVD) or with multiple risk factors by 31% compared to standard-of-care treatment. an additional 31% an additional 31% yFeed_highLightText__NxlGi">first FDA FDA NxlGi">the American Heart Association Healthline 5,522 aryFeed_highLightText__NxlGi">Nowlan FDA ie. ie. FDA Nowlan a number of years t__NxlGi">Chen Healthline ChenNowlan FDA Chen Chen Chen the last 10 years